Recent Advances in Monitoring Technologies for Cardiac Troponin I: A Pivotal Biomarker in Cardiovascular Diseases
Cardiovascular diseases (CVDs) are among the leading causes of morbidity and mortality rates globally, presenting a severe threat to human health and life. Acute myocardial infarction (AMI) is one of the most common and extremely severe disorders within CVDs, causing an estimated 17.5 million deaths...
Saved in:
Main Authors: | Ning Zhang, Yusong Wang, Fachuang Li, Yuxin Zhu, Zheng Fu, Mengda Jia, Xiaoran Zhan, Wanqing Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/6/858 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic Efficacy of Combined N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) Testing in Myocardial Injury of Children with Mycoplasma Pneumoniae Pneumonia
by: Yang M, et al.
Published: (2025-06-01) -
Evaluation of some heart enzymes and Iron levels in β-thalassemia patients in Thi-Qar City, Iraq
by: Ahmed jaber ibrahim, et al.
Published: (2024-06-01) -
Methodological Considerations in Humidex and Schizophrenia Research [Letter]
by: Zubaidah T, et al.
Published: (2025-05-01) -
Cardiorespiratory Fitness and Highly Sensitive Cardiac Troponin Levels in a Preventive Medicine Cohort
by: Laura F. DeFina, et al.
Published: (2016-12-01) -
The effects of early exercise on cardiovascular biomarkers in patients with congestive heart failure
by: Yanxiang Sun, et al.
Published: (2025-08-01)